More data, less DNA. With #SPRQ chemistry, Signios Biosciences is unlocking #HiFisequencing for tough samples—boosting output and expanding access to more sample types. 🔗 See how they’re using SPRQ to scale impact and access: bit.ly/4jgpTbn #PacBio #PacBioSPRQ

Dissecting LUSC heterogeneity with scRNA-seq: See how researchers identified KLF4-driven hillock-like states in our new #solidtumor profiling note. 46743515.fs1.hubspotusercontent-na1.net/hubfs/467435.... #CancerResearch #Genomics #SingleCell #SigniosBio #ScienceOfSignals

See the bigger picture in cancer with #SigniosBio's @pacbio.bsky.social #HiFi long reads. Detect SNVs, Indels, SVs, full-length RNA isoforms & DNA methylation (#5mC) in one workflow. Explore what's possible: www.signiosbio.com/contact/ #LongReads #CancerGenomics #Epigenetics #Multiomics

Happy #DNADay! "Genes are the foundation of humanity. We stand at the threshold of a new era—one that gives us the power to prevent or cure all genetically linked diseases." – Dr. Felix Olale, CEO, #SigniosBio Celebrating the power of #genomics to shape health. #Genetics #DNA #ScienceofSignals

New Lung Cancer Case Study with Dr. Mukesh Nyati at #AACR25! See how Signios Bio's spatial transcriptomics mapped the TME in KRAS models. Discuss the findings with Dr. Nyati at Booth #2364 on Tuesday (29th) at 2pm! #SigniosBio #SpatialTranscriptomics #CancerResearch #ScienceOfSignals

Meet #SigniosBio (formerly MedGenome) at #AACR25 — Booth 2364, April 25–30 in Chicago. Let’s talk multiomics in #oncology: solid tumors, heme, IO & more. Same expert team, new focus. #ScienceOfSignals Schedule a meeting: hubs.ly/Q03jn_V20 #Genomics #CancerResearch

New Lung Cancer Case Study with Dr. Mukesh Nyati at #AACR2025! See how Signios Bio's spatial transcriptomics mapped the TME in KRAS models. Discuss the findings with Dr. Nyati at Booth #2364 on Tuesday (29th) at 2pm! #SigniosBio #SpatialTranscriptomics #CancerResearch #ScienceOfSignals

Meet #SigniosBio (formerly MedGenome) at #AACR2025 — Booth 2364, April 25–30 in Chicago. Let’s talk multiomics in #oncology: solid tumors, heme, IO & more. Same expert team, new focus. #ScienceOfSignals Schedule a meeting: hubs.ly/Q03jn_V20 #Genomics #CancerResearch

What drives early-onset Parkinson’s (diagnosed ≤50) in India? Research involving Signios Bio, MedGenome & PRAI found PRKN variants are key contributors, especially in younger patients. pubmed.ncbi.nlm.nih.gov/38014556/ #ParkinsonsAwarenessMonth #YOPD #PDResearch #ScienceOfSignals

Proud to see our own Dr. Harsha Gowda featured by @pacbio.bsky.social. Dr. Gowda shares how #SigniosBio is using #SPRQ chemistry on the Revio system to boost output, lower input, and support clinical, pharma, and academic research. Thanks to the PacBio team! www.pacb.com/blog/custome...

PacBio@pacbio.bsky.social · last yr.

What happens when your chemistry upgrade changes the game? With #SPRQ chemistry on the Revio system, Signios Biosciences is unlocking more data, more flexibility, and new possibilities across their global operations. Read the story: bit.ly/4jgpTbn #PacBioSPRQ #PacBio

Personalized, proactive, & precise medicine: that's our vision. Learn more about the future of healthcare with Signios Bio in this docuseries: apnews.com/direct?prx_t... #SigniosBio #ScienceOfSignals #PrecisionMedicine

Welcome to Signios Bio, where we are decoding the future of healthcare with multiomics and AI-powered bioinformatics. www.signiosbio.com #SigniosBio #Multiomics #ScienceOfSignals